Stay ahead in the rapidly evolving landscape of medical device regulation with this in-depth training on the FDA’s classification of phase-changing fiducial markers for radiation therapy. This course offers practical guidance on compliance, performance data requirements, biocompatibility and sterility standards, usability validation, and essential labeling rules under the newly established class II special controls. Learn how to streamline your regulatory submissions, ensure patient safety, and avoid costly market delays while supporting innovation in radiation therapy.
In this course you will learn the following:
* Understand the FDA’s rationale for classifying the device as class II with special controls.
* Identify the specific special controls and general controls applicable to the device.
* Implement the required testing, labeling, and documentation to achieve compliance.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.
